Large Pharmaceuticals

Torrent Pharmaceuticals Ltd.

TORNTPHARM

Market Cap
₹1,69,316 Cr.
P/E
78.26

Torrent Pharmaceuticals Ltd.

  • Torrent Pharma
  • Cipla
  • Zydus Lifesciences
  • TJI Pharma

FAQs on Torrent Pharmaceuticals Ltd. Shareprice

Torrent Pharma has given better returns compared to its competitors.
Torrent Pharma has grown at ~34.72% over the last 3yrs while peers have grown at a median rate of 15.51%

Yes, Torrent Pharma is expensive.
Latest PE of Torrent Pharma is 78.26, while 3 year average PE is 59.09.
Also latest EV/EBITDA of Torrent Pharma is 40.13 while 3yr average is 27.66.

View FAQ's On Business

Growth Table

  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Balance Sheet

  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Cash Flow

  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Quarterly Results

  • Torrent Pharmaceuticals Ltd.
  • Cipla
  • Zydus Lifesciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Torrent Pharmaceuticals Ltd. Financials

Balance sheet of Torrent Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Torrent Pharma is increasing.
Latest net debt of Torrent Pharma is ₹12,468 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹1,868 Crs.

Yes, profit is increasing.
The profit of Torrent Pharma is ₹2,163 Crs for Mar 2026, ₹1,911 Crs for Mar 2025 and ₹1,656 Crs for Mar 2024

The company seems to pay a good stable dividend.
Torrent Pharma latest dividend payout ratio is 59.45% and 3yr average dividend payout ratio is 57.78%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech